Haemonetics (HAE) Operating Income Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Haemonetics | 3.18 Bn | 2.93 Bn | 198.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -1.69% |
| Dec 27, 2025 | 10.76% |
| Sep 27, 2025 | -0.10% |
| Jun 28, 2025 | 35.68% |
| Mar 29, 2025 | 22.36% |
| Dec 28, 2024 | 7.61% |
| Sep 28, 2024 | 0.78% |
| Jun 29, 2024 | 37.91% |
| Mar 30, 2024 | 4.65% |
| Dec 30, 2023 | 10.18% |
| Sep 30, 2023 | 6.25% |
| Jul 1, 2023 | 58.92% |
| Apr 1, 2023 | 19.82% |
| Dec 31, 2022 | 111.90% |
| Oct 1, 2022 | 14.01% |
| Jul 2, 2022 | 13.12% |
| Apr 2, 2022 | 18.47% |
| Jan 1, 2022 | 10.94% |
| Oct 2, 2021 | -0.23% |
| Jul 3, 2021 | 16.83% |
| Apr 3, 2021 | -30.71% |
| Dec 26, 2020 | 21.62% |
| Sep 26, 2020 | 25.11% |
| Jun 27, 2020 | 26.57% |
| Mar 28, 2020 | 17.65% |
| Dec 28, 2019 | 17.51% |
| Sep 28, 2019 | 32.01% |
| Jun 29, 2019 | -51.51% |
| Mar 30, 2019 | 14.04% |
| Dec 29, 2018 | 10.04% |
| Sep 29, 2018 | 2.44% |
| Jun 30, 2018 | 22.87% |
| Mar 31, 2018 | -4.22% |
| Dec 30, 2017 | -42.23% |
| Sep 30, 2017 | 19.63% |
| Jul 1, 2017 | 4.90% |
| Apr 1, 2017 | -36.53% |
| Dec 31, 2016 | -3.48% |
| Oct 1, 2016 | 5.96% |
| Jul 2, 2016 | -18.43% |
| Apr 2, 2016 | -17.00% |
| Dec 26, 2015 | -32.88% |
| Sep 26, 2015 | -7.88% |
| Jun 27, 2015 | -31.66% |
| Mar 28, 2015 | 23.01% |
| Dec 27, 2014 | -6.70% |
| Sep 27, 2014 | -14.42% |
| Jun 28, 2014 | -15.59% |